IFCC Working Group Recommendations for Assessing Commutability Part 1: General Experimental Design

Author:

Miller W Greg1,Schimmel Heinz2,Rej Robert3,Greenberg Neil4,Ceriotti Ferruccio5,Burns Chris6,Budd Jeffrey R7,Weykamp Cas8,Delatour Vincent9,Nilsson Göran10,MacKenzie Finlay11,Panteghini Mauro12,Keller Thomas13,Camara Johanna E14,Zegers Ingrid2,Vesper Hubert W15

Affiliation:

1. Department of Pathology, Virginia Commonwealth University, Richmond, VA

2. European Commission, Joint Research Centre (JRC), Directorate F, Geel, Belgium

3. Wadsworth Center for Laboratories and Research, New York State Department of Health, and School of Public Health, State University of New York at Albany, Albany, NY

4. Neil Greenberg Consulting, LLC, Rochester, NY

5. Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

6. National Institute for Biological Standards and Control, A Centre of the MHRA, Hertfordshire, UK

7. Beckman Coulter, Chaska, MN

8. Queen Beatrix Hospital, Winterswijk, the Netherlands

9. Laboratoire national de métrologie et d'essais (LNE), Paris, France

10. Uppsala, Sweden

11. Birmingham Quality/UK NEQAS, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

12. Research Centre for Metrological Traceability in Laboratory Medicine (CIRME), University of Milan, Milan, Italy

13. ACOMED Statistic, Leipzig, Germany

14. National Institute of Standards and Technology, Gaithersburg, MD

15. Centers for Disease Control and Prevention, Atlanta, GA

Abstract

Abstract Commutability is a property of a reference material (RM) that relates to the closeness of agreement between results for an RM and results for clinical samples (CSs) when measured by ≥2 measurement procedures (MPs). Commutability of RMs used in a calibration traceability scheme is an essential property for them to be fit for purpose. Similarly, commutability of trueness controls or external quality assessment samples is essential when those materials are used to assess trueness of results for CSs. This report is part 1 of a 3-part series describing how to assess commutability of RMs. Part 1 defines commutability and addresses critical components of the experimental design for commutability assessment, including selection of individual CSs, use of pooled CSs, qualification of MPs for inclusion, establishing criteria for the determination that an RM is commutable, generalization of commutability conclusions to future measurements made with the MPs included in the assessment, and information regarding commutability to be included in the certificate for an RM. Parts 2 and 3 in the series present 2 different statistical approaches to commutability assessment that use fixed criteria related to the medical decisions that will be made using the laboratory test results.

Publisher

Oxford University Press (OUP)

Subject

Biochemistry (medical),Clinical Biochemistry

Reference12 articles.

1. IFCC working group recommendations for assessing commutability part 2: based on the difference in bias between a reference material and clinical samples;Nilsson;Clin Chem,2018

2. IFCC working group recommendations for assessing commutability part 3: based on the calibration effectiveness of a reference material;Budd;Clin Chem,2018

3. International vocabulary of metrology—basic and general concepts and associated terms (VIM),2012

4. Evaluation of commutability of processed samples; approved guideline,2014

5. Characterization and qualification of commutable reference materials for laboratory medicine; approved guideline,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3